Pseudomonas aeruginosa infection therapeutic(C3J Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePseudomonas aeruginosa infection therapeutic(C3J Therapeutics)
Drug Alias NameG10KHc
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCystic FibrosisPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesC3j Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC3j Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCystic FibrosisPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A